Skip to content

UnitedHealth Group UNH Optum Rx — Premiums

Other segment segments

UnitedHealthcare
$82.99B+1.8%
Optum Health
$4.58B-8.9%
Optum Insight
$0

Similar metrics at other companies

Humana logo
HUMProduct — Premiums
$37.71B+23.6%
CVS Health logo
CVSPremiums — Revenues from external customers
$33.79B+3.0%
Elevance Health logo
ELVCarelonRx Segment — Premiums
$0
Alignment Healthcare logo
ALHCPremium — Earned premiums
$1.23B+33.8%
Molina Healthcare logo
MOHOther — Premium revenue
$2M-93.5%
Globe Life logo
GLOther — Premium
$49.7M+5.3%

Other financials

Income statement

See full
Revenue$111.72B+2.0%
Gross profit$98.9B+1.8%
Operating income$9.0B-1.4%
Net income$6.3B-0.2%
EPS (diluted)$6.90+0.7%

Balance sheet

See full
Cash & equivalents$28.0B-8.8%
Total debt$77.9B-4.1%
Total equity$103.90B+3.1%
Total assets$312.64B+0.9%

Cash flow

See full
Operating cash flow$8.9B+63.3%
CapEx$763.0M-15.0%
Free cash flow$8.1B+78.8%

Valuation

See full
Market cap$382.09B+49.3%
Enterprise value$432.01B+40.9%
P/E31.7×+19.7×
P/S0.9×+0.2×

Profitability

See full
Gross margin88.6%+0.4pp
Operating margin4.2%-4.0pp
Net margin2.7%-2.7pp
FCF margin4.4%-1.7pp

Returns & leverage

See full
Return on equity11.8%-11.1pp
Debt / equity0.8×-0.1×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by UnitedHealth Group in its filing.

Tagged under the XBRL concept us-gaap:PremiumsEarnedNet.

The official record: UnitedHealth Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about UnitedHealth Group's optum rx — premiums.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UnitedHealth Group's optum rx — premiums?
UnitedHealth Group (UNH) reported optum rx — premiums of $0 in Q1 2026.
What does optum rx — premiums mean?
Represents the revenue generated from insurance-like risk-bearing contracts within the pharmacy benefit management segment. This metric reflects the premiums collected for managing pharmacy benefits where the entity assumes financial risk for drug costs.